Loading…

Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin

This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV...

Full description

Saved in:
Bibliographic Details
Published in:PLoS ONE 2016, Vol.11 (12), p.e0168468
Main Authors: Álvarez-Marín, Rocío, López-Rojas, Rafael, Márquez, Juan Antonio, Gómez, María José, Molina, José, Cisneros, José Miguel, Ortiz-Leyba, Carlos, Aznar, Javier, Garnacho-Montero, José, Pachón, Jerónimo
Format: Report
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 12
container_start_page e0168468
container_title PLoS ONE
container_volume 11
creator Álvarez-Marín, Rocío
López-Rojas, Rafael
Márquez, Juan Antonio
Gómez, María José
Molina, José
Cisneros, José Miguel
Ortiz-Leyba, Carlos
Aznar, Javier
Garnacho-Montero, José
Pachón, Jerónimo
description This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.
doi_str_mv 10.1371/journal.pone.0168468
format report
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_incontextgauss_IOV_A474490072</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A474490072</galeid><sourcerecordid>A474490072</sourcerecordid><originalsourceid>FETCH-gale_incontextgauss_IOV_A4744900723</originalsourceid><addsrcrecordid>eNqVjs1Kw1AQhS-iYP15AxezdZF408S0XZZaaUFQbOm2TNJpOiWdW3LnUvuAvpepKLh1dQ6Hj49jzF1i4yTtJQ9bFxrBOt47odgmeT_L-2emkwzSbpR3bXr-p1-aK--31j6m_TzvmM-Rq9krCzw5jxXBgXXjgsKLwxVLdZoJph7G6zWXWLILHg4bEpg3hHoiRtgUuCehXfROvpWhKAxLFlJXYKnUQIFhhyLMsCBRrlFdEw29dyWj0grehMLOCWMrC74diiPMtEEW_30IJlxtYBZ8SXvlgmvWI6iD3_M35mKNtafbn7w298_j-WgSVVjTkqV0ovShVSv3y-nrYjnMelk2sLbXTf_DfgEDBHjC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>report</recordtype></control><display><type>report</type><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</creator><creatorcontrib>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</creatorcontrib><description>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0168468</identifier><language>eng</language><publisher>Public Library of Science</publisher><subject>Acinetobacter infections ; Care and treatment ; Colistin ; Dose-response relationship ; Health aspects ; Ventilator-associated pneumonia</subject><ispartof>PLoS ONE, 2016, Vol.11 (12), p.e0168468</ispartof><tpages>e0168468</tpages><format>e0168468</format><rights>COPYRIGHT 2016 Public Library of Science</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,780,4476,27902</link.rule.ids></links><search><creatorcontrib>Álvarez-Marín, Rocío</creatorcontrib><creatorcontrib>López-Rojas, Rafael</creatorcontrib><creatorcontrib>Márquez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez, María José</creatorcontrib><creatorcontrib>Molina, José</creatorcontrib><creatorcontrib>Cisneros, José Miguel</creatorcontrib><creatorcontrib>Ortiz-Leyba, Carlos</creatorcontrib><creatorcontrib>Aznar, Javier</creatorcontrib><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Pachón, Jerónimo</creatorcontrib><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><title>PLoS ONE</title><description>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</description><subject>Acinetobacter infections</subject><subject>Care and treatment</subject><subject>Colistin</subject><subject>Dose-response relationship</subject><subject>Health aspects</subject><subject>Ventilator-associated pneumonia</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>report</rsrctype><creationdate>2016</creationdate><recordtype>report</recordtype><recordid>eNqVjs1Kw1AQhS-iYP15AxezdZF408S0XZZaaUFQbOm2TNJpOiWdW3LnUvuAvpepKLh1dQ6Hj49jzF1i4yTtJQ9bFxrBOt47odgmeT_L-2emkwzSbpR3bXr-p1-aK--31j6m_TzvmM-Rq9krCzw5jxXBgXXjgsKLwxVLdZoJph7G6zWXWLILHg4bEpg3hHoiRtgUuCehXfROvpWhKAxLFlJXYKnUQIFhhyLMsCBRrlFdEw29dyWj0grehMLOCWMrC74diiPMtEEW_30IJlxtYBZ8SXvlgmvWI6iD3_M35mKNtafbn7w298_j-WgSVVjTkqV0ovShVSv3y-nrYjnMelk2sLbXTf_DfgEDBHjC</recordid><startdate>20161219</startdate><enddate>20161219</enddate><creator>Álvarez-Marín, Rocío</creator><creator>López-Rojas, Rafael</creator><creator>Márquez, Juan Antonio</creator><creator>Gómez, María José</creator><creator>Molina, José</creator><creator>Cisneros, José Miguel</creator><creator>Ortiz-Leyba, Carlos</creator><creator>Aznar, Javier</creator><creator>Garnacho-Montero, José</creator><creator>Pachón, Jerónimo</creator><general>Public Library of Science</general><scope>IOV</scope></search><sort><creationdate>20161219</creationdate><title>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</title><author>Álvarez-Marín, Rocío ; López-Rojas, Rafael ; Márquez, Juan Antonio ; Gómez, María José ; Molina, José ; Cisneros, José Miguel ; Ortiz-Leyba, Carlos ; Aznar, Javier ; Garnacho-Montero, José ; Pachón, Jerónimo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_incontextgauss_IOV_A4744900723</frbrgroupid><rsrctype>reports</rsrctype><prefilter>reports</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acinetobacter infections</topic><topic>Care and treatment</topic><topic>Colistin</topic><topic>Dose-response relationship</topic><topic>Health aspects</topic><topic>Ventilator-associated pneumonia</topic><toplevel>online_resources</toplevel><creatorcontrib>Álvarez-Marín, Rocío</creatorcontrib><creatorcontrib>López-Rojas, Rafael</creatorcontrib><creatorcontrib>Márquez, Juan Antonio</creatorcontrib><creatorcontrib>Gómez, María José</creatorcontrib><creatorcontrib>Molina, José</creatorcontrib><creatorcontrib>Cisneros, José Miguel</creatorcontrib><creatorcontrib>Ortiz-Leyba, Carlos</creatorcontrib><creatorcontrib>Aznar, Javier</creatorcontrib><creatorcontrib>Garnacho-Montero, José</creatorcontrib><creatorcontrib>Pachón, Jerónimo</creatorcontrib><collection>Gale In Context: Opposing Viewpoints</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Álvarez-Marín, Rocío</au><au>López-Rojas, Rafael</au><au>Márquez, Juan Antonio</au><au>Gómez, María José</au><au>Molina, José</au><au>Cisneros, José Miguel</au><au>Ortiz-Leyba, Carlos</au><au>Aznar, Javier</au><au>Garnacho-Montero, José</au><au>Pachón, Jerónimo</au><format>book</format><genre>unknown</genre><ristype>RPRT</ristype><atitle>Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin</atitle><jtitle>PLoS ONE</jtitle><date>2016-12-19</date><risdate>2016</risdate><volume>11</volume><issue>12</issue><spage>e0168468</spage><pages>e0168468-</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation [greater than or equal to]6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC.sub.90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.</abstract><pub>Public Library of Science</pub><doi>10.1371/journal.pone.0168468</doi><tpages>e0168468</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PLoS ONE, 2016, Vol.11 (12), p.e0168468
issn 1932-6203
1932-6203
language eng
recordid cdi_gale_incontextgauss_IOV_A474490072
source Publicly Available Content Database; PubMed Central
subjects Acinetobacter infections
Care and treatment
Colistin
Dose-response relationship
Health aspects
Ventilator-associated pneumonia
title Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-23T23%3A38%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.atitle=Colistin%20Dosage%20without%20Loading%20Dose%20Is%20Efficacious%20when%20Treating%20Carbapenem-Resistant%20Acinetobacter%20baumannii%20Ventilator-Associated%20Pneumonia%20Caused%20by%20Strains%20with%20High%20Susceptibility%20to%20Colistin&rft.jtitle=PLoS%20ONE&rft.au=%C3%81lvarez-Mar%C3%ADn,%20Roc%C3%ADo&rft.date=2016-12-19&rft.volume=11&rft.issue=12&rft.spage=e0168468&rft.pages=e0168468-&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0168468&rft_dat=%3Cgale%3EA474490072%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-gale_incontextgauss_IOV_A4744900723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A474490072&rfr_iscdi=true